Biomolecules MDPI

🎓 Welcome to our Editorial Board Dr. Saida Ortolano, of the Rare Diseases and Pediatric Medicine Research Group at the Galicia Sur Health Research Institute (IIS Galicia Sur, SERGAS-UVIGO), Hospital Álvaro Cunqueiro, Vigo (Spain), has joined Biomolecules as an Editorial Board Member. Dr. Ortolano's research focuses on lysosomal storage disorders, with a particular emphasis on Fabry disease. Her work covers newborn screening and patient detection in the Spanish population, plasma biomarkers for monitoring disease progression, and therapeutic strategies ranging from pharmacological chaperones that increase α-galactosidase A activity to AAV9-based gene therapy. Her group also studies autophagy and lysosomal network defects in other rare and neurodegenerative conditions. ➡️ https://brnw.ch/21x5W32 #FabryDisease #LysosomalDisorders #GeneTherapy #RareDiseases #Autophagy

🎓 Welcome to our Editorial Board Prof. Dr. Qing-Bai She, Professor in the Department of Pharmacology and Nutritional Sciences and member of the Markey Cancer Center at the University of Kentucky (Lexington, KY, USA), has joined Biomolecules as an Editorial Board Member. Prof. She's research focuses on the oncogenic signaling and metabolic pathways that drive colorectal cancer (CRC) progression, metastasis, and therapeutic resistance. His laboratory identified 4E-BP1 as a critical node integrating the PI3K/AKT and RAS/RAF/MEK/ERK pathways in CRC and has developed a new class of natural product-based inhibitors targeting translational control. More recently, his group uncovered two novel neuropilin-1 (NRP1) splice variants that promote CRC metastasis through endosomal signaling, along with a key role for spermine synthase (SMS) in driving tumorigenesis in cooperation with MYC. ➡️ https://brnw.ch/21x5QeO #ColorectalCancer #mTOR #TranslationalControl #CancerMetabolism #CancerSignaling

📢 Deadline Extended! 🌟 Explore the "The Heme Oxygenase/Biliverdin Reductase System in Human Health and Disease: New Molecular Insights and Therapeutic Targets" Special Issue, guest-edited by Prof. Dr. Cesare Mancuso. Following discussions with our contributors, we have extended the submission deadline to give all interested authors more time to prepare their manuscripts. 📅 New deadline: June 30, 2027 📊 Where the Special Issue stands: 8 papers published 3 manuscripts under review At least 8 more scholars committed to submitting We welcome original research articles, reviews, and short communications on the HO/BVR system, from new mechanistic insights to therapeutic opportunities in neurological, cardiovascular, metabolic, and other diseases. More details ➡️ https://brnw.ch/21x5Q6e #Biomolecules #MDPI #HemeOxygenase #BiliverdinReductase #CallForPapers #OpenAccess

🎓 Welcome to our Editorial Board Prof. Dr. Vijay K. Singh, Professor in the Department of Pharmacology and Molecular Therapeutics at the Uniformed Services University of the Health Sciences (Bethesda, MD, USA), has joined Biomolecules as an Editorial Board Member. Prof. Singh's research focuses on developing medical countermeasures for acute radiation syndrome (ARS) and the delayed effects of acute radiation exposure, following the US FDA Animal Rule. Several of these candidates, including BIO 300 (genistein) and gamma-tocotrienol, have reached Investigational New Drug status. His laboratory also identifies and validates non-invasive biomarkers of radiation injury and countermeasure efficacy, drawing on metabolomics, lipidomics, proteomics, transcriptomics and miRNA profiling in small and large animal models. ➡️ https://brnw.ch/21x5JFF #RadiationBiology #RadiationCountermeasures #Biomarkers #Multiomics #SignalTransduction

🏆 Congratulations to Dr. João Basso (University of Coimbra, Portugal), winner of the Biomolecules Best PhD Thesis Award! This award recognizes outstanding PhD theses in biochemistry and molecular biology. The prize includes CHF 800, a certificate, and a voucher waiving the article processing charge for one future submission to the journal. 👉 Learn more about the award: https://brnw.ch/21x6vIE Well deserved, Dr. Basso! #BiomoleculesAward #PhDThesis #EarlyCareerResearcher

🔬Join us for the 12th #Biomolecules Webinar, "AI-Driven Drug Discovery: Opportunities and Challenges in Molecular Research (2nd Edition)"! 🔗Register now: https://brnw.ch/21x6cDH 🎓Chaired by Dr. Carmen Di Giovanni (University of Naples Federico II), with talks from Prof. Ashkan Golshani (Carleton University and University of Ottawa) and Dr. Pietro Delre (University of Naples Federico II). How is AI changing the way we find new therapeutics? This session looks at AI-guided peptide design and generative AI for molecular design, and closes with a live Q&A where you can put your questions to the speakers. 📅 15 October 2026 ⏰ 15:00 CEST | 9:00 EDT | 21:00 CST Asia 💻 Online More details: https://brnw.ch/21x6cDI #DrugDiscovery #ArtificialIntelligence #PeptideDesign #MolecularModeling #Webinar